CDT Equity Inc

Research CDT Equity Inc (CDT) on Bullrun: market cap USD 2.83M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCDT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.83M
• Financial periodFY2025
• Net income-USD 39.22M

Valuation Snapshot

latest market cap is USD 2.83M.

About CDT Equity Inc

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus;

Frequently asked questions

What is CDT Equity Inc's market cap?

CDT Equity Inc's market capitalization is USD 2.83M.

What does CDT Equity Inc do?

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets.